Real-world progression, treatment, and survival outcomes during rapid adoption of immunotherapy for advanced non-small cell lung cancer.

Khozin S, Miksad RA, Adami J, Boyd M, Brown NR, Gossai A, Kaganman I, Kuk D, Rockland JM, Pazdur R, Torres AZ, Zhi J, Abernethy AP

Open source

DOI
10.1002/cncr.32383
Published
2019 Nov 15
Container
Cancer
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cncr.32383,
  title = {Real-world progression, treatment, and survival outcomes during rapid adoption of immunotherapy for advanced non-small cell lung cancer.},
  author = {Khozin S and Miksad RA and Adami J and Boyd M and Brown NR and Gossai A and Kaganman I and Kuk D and Rockland JM and Pazdur R and Torres AZ and Zhi J and Abernethy AP},
  year = {2019},
  journal = {Cancer},
  doi = {10.1002/cncr.32383},
  url = {https://doi.org/10.1002/cncr.32383}
}

RIS

TY  - JOUR
TI  - Real-world progression, treatment, and survival outcomes during rapid adoption of immunotherapy for advanced non-small cell lung cancer.
AU  - Khozin S
AU  - Miksad RA
AU  - Adami J
AU  - Boyd M
AU  - Brown NR
AU  - Gossai A
AU  - Kaganman I
AU  - Kuk D
AU  - Rockland JM
AU  - Pazdur R
AU  - Torres AZ
AU  - Zhi J
AU  - Abernethy AP
PY  - 2019
JO  - Cancer
DO  - 10.1002/cncr.32383
UR  - https://doi.org/10.1002/cncr.32383
ER  - 

APA

S, K., RA, M., J, A., M, B., NR, B., A, G., I, K., D, K., JM, R., R, P., AZ, T., J, Z., & AP, A. (2019). Real-world progression, treatment, and survival outcomes during rapid adoption of immunotherapy for advanced non-small cell lung cancer.. Cancer. https://doi.org/10.1002/cncr.32383

Source records